最高の肉腫医師 - トップ107名の医師

Bülent Karagöz教授は33年の経験の経験を持つ肉腫専門医であり、アナドル医療センターにて腫瘍生物学および免疫療法を専門としています。

• GATA Haydarpaşa研修病院 腫瘍内科部長
• イスタンブール・オカン大学医学部 教授
• がん研究における40本以上の論文著者
• トルコ腫瘍内科学会 会員

アナドル医療センターにて腫瘍内科を専門とする。化学療法および分子標的療法を専門領域とする。

• マルマラ大学にて腫瘍内科の専門医研修を修了
• ハイダルパシャ・ヌムネ研修研究病院にて腫瘍内科部門の元部門長
• 国際臨床研究に参加経験あり
• トルコの専門医試験にて全国3位を獲得

Mustafa Solak は1,100件以上のがん治療を実施し、世界屈指のがん専門施設であるMDアンダーソンがんセンターで研鑽を積みました。

• 臨床腫瘍学における20年の経験の経験
• 乳がん、肺がん、消化器がんを専門とする
• ハジェテペ大学がん研究所にてフェローシップ研修を修了
• MDアンダーソンがんセンターの元スタッフ

テクノン医療センターの肉腫ユニット長 — ガルセラン医師は1,200件以上の肉腫治療を行ってきました。

• 39年の経験 腫瘍学を専門とし、肉腫を中心に診療
• バル・デブロン大学病院の泌尿生殖器・中枢神経系・肉腫・原発不明腫瘍ユニットを統括
• スペイン肉腫研究グループ（GEIS）会員
• 腫瘍学に関する査読付き論文を120本以上発表
• スペインにおける肉腫治療の第一人者として評価されている

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.

職歴

• 2006年5月 – 2007年10月：ウルギュップ国立病院（産科婦人科における義務従事）
• 2008年7月 – 2009年7月：エドレミット軍病院（軍務）
• 2009年11月 – 2015年4月：アダナ・バシュケント大学病院、産科婦人科
• 2015年5月 – 2018年5月：マルマラ大学、婦人科腫瘍学レジデンシープログラム
• 2018年7月 – 2024年9月：ウムラニエ教育研究病院
• 2024年12月 – 現在：アナドル医療センター

海外診療経験

• 2009年8月 – 2009年11月：シバ・テル・ハショメル医療センター、イスラエル
• 2014年7月：アスクレピオスクリニック、ハンブルク、ドイツ
• 2018年2月 – 2018年3月：シャリテ病院、ベルリン、ドイツ

学歴

• 医学博士研究員：マルマラ大学、婦人科腫瘍学部門、2015年－2018年、イスタンブール
• 医学専門研修：バシュケント大学医学部、産科婦人科、2001年－2006年、アンカラ
• 医学部：イスタンブール大学チェッラーパシャ医学部、1994年－2000年、イスタンブール

専門分野

• 婦人科腫瘍学における外科治療、およびその他の基本的・高度な婦人科手術。妊孕性温存手術、腹腔鏡手術、ロボット支援手術に特に精通している。

学会・団体所属

• ESGO – 欧州婦人科腫瘍学会（2015年より会員）
• TRSGO – トルコ婦人科腫瘍学会（2016年より会員）

メリムスキー教授は、ソウラスキー医療センターの骨・軟部腫瘍科を統括し、41年の経験以上にわたる肉腫治療の専門家です。

• パリのグスタフ・ルッシー研究所にて肉腫治療のフェローシップを修了
• イスラエル臨床腫瘍・放射線治療学会会長
• ESMO肉腫グループおよびASCOの現役メンバー
• 肉腫および腫瘍学研究に関する論文を多数発表

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Dr. Mehmet Taner Ozdemir is an orthopedist and bone tumor specialist at Anadolu Medical Center. He completed training at the Hospital for Special Surgery in New York. This facility is a top-ranked center for orthopedics in the United States. Dr. Ozdemir focuses on orthopedic oncology and complex trauma surgery.

• Member of the European Musculoskeletal Tumor Society.
• Treats bone and soft tissue tumors, including sarcoma and chondrosarcoma.
• Performs joint replacements, arthroscopic surgeries, and stem cell therapy.
• Authored over 15 international and national medical publications.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

ガレニア病院の外科腫瘍専門医（資格認定済み）。肉腫治療を専門とし、アナワク大学でも教鞭を執る。

• Centro Medico Nacional 20 de Noviembre にて外科腫瘍学トレーニングを修了
• Conacem認定取得（2020〜2030年）– メキシコ最高峰の医療資格認定
• SMEO（メキシコを代表する腫瘍学会）会員
• メキシコ社会保険機構（Instituto Mexicano del Seguro Social）にて外科研修を修了

この医師は化学療法と放射線療法の専門家であり、乳がん、子宮がん、前立腺がん、消化管がん、肺がん、腎臓がん、膀胱がんを含む様々な腫瘍性疾患の治療に焦点を当てています。医師は化学療法、放射線療法、生物学的がん治療などの先進的な治療法を用い、がん治療後のリハビリテーションも提供しています。

1988年からの経験を持ち、2009年からSourasky (Ichilov) Medical Centerで上級腫瘍専門医として勤務しており、Rambam Medical CenterおよびSourasky Medical Centerで重要な役職を歴任しています。医師は30以上の科学論文に貢献しており、がん治療の臨床試験にも関与しています。

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

メフメット・カラジャ教授は、腹腔鏡手術およびハイリスク妊娠の専門知識を有し、婦人科がんを専門として31年の経験以上のキャリアを持ちます。

• ディクレ大学にて博士号を取得した婦人科・産科学教授
• 厚生省による婦人科腫瘍低侵襲手術の研修修了
• アクデニズ大学およびカフカス大学の教員
• 主要病院における10年以上のリーダーシップ職の経験

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.

• Provides immunotherapy, biological therapy, and hormone treatments for various cancer types.
• Treats rare and difficult conditions like thymoma, chordoma, and Ewing's sarcoma.
• Performs PET-CT scans and comprehensive oncological check-ups for men and women.
• Uses JCI-accredited facilities with systems like TrueBeam STx and Halcyon for treatment.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).